Literature DB >> 1988305

Clinical features and response to treatment of infradiaphragmatic Hodgkin's disease.

N Villamor1, J C Reverter, J M Martí, E Montserrat, C Rozman.   

Abstract

Among 247 patients with Hodgkin's disease, initial disease presentation was restricted to infradiaphragmatic sites in 17 (6.9%). Advanced age, B symptoms, increased ESR, low lymphocyte and platelet counts, as well as advanced pathological stage and lymphocyte depletion histology were common presenting features of these patients. 7 patients with infradiaphragmatic disease had isolated involvement of inguinofemoral nodes ("peripheral" group) and 10 had only intraabdominal disease ("central" group). Clinical characteristics of patients with "central" forms were different from those with supradiaphragmatic disease, but no differences were observed between "peripheral" infradiaphragmatic and supradiaphragmatic groups. Complete remission was achieved in the 82.2% of patients with infradiaphragmatic disease. Overall survival was 68% at 5 years, and disease-free survival was 74%. No statistically significant differences were observed in complete remission rates, survival, and disease-free survival when supradiaphragmatic, "central" infradiaphragmatic and "peripheral" infradiaphragmatic forms were compared.

Entities:  

Mesh:

Year:  1991        PMID: 1988305     DOI: 10.1111/j.1600-0609.1991.tb00511.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  3 in total

1.  Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease.

Authors:  R García; J M Hernández; M D Caballero; M González; J Galende; M C del Cañizo; L Vázquez; J F San Miguel
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

2.  Hodgkin's disease diagnosed post mortem: a population based study.

Authors:  H Hasle; A Mellemgaard
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

3.  Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT.

Authors:  Cédric Rossi; Morgane Mounier; Pauline Brice; Violaine Safar; Emmanuelle Nicolas-Virelizier; Philippe Rey; Aspasia Stamatoullas-Bastard; Marion Alcantara; Adrien Chauchet; Emilie Reboursière; Lauriane Filliatre; Aurore Perrot; Sylvain Garciaz; Gilles Salles; Bertrand Coiffier; Hervé Ghesquières; René-Olivier Casasnovas
Journal:  Oncotarget       Date:  2017-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.